These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20143870)

  • 1. Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.
    Abu Shehab M; Khosravi J; Han VK; Shilton BH; Gupta MB
    J Proteome Res; 2010 Apr; 9(4):1873-81. PubMed ID: 20143870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction.
    Abu Shehab M; Inoue S; Han VK; Gupta MB
    J Proteome Res; 2009 Nov; 8(11):5325-35. PubMed ID: 19731965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IGFBP-1 is phosphorylated on 3 serine residues: effects of site-directed mutagenesis of the major phosphoserine.
    Jones JI; Busby WH; Wright G; Clemmons DR
    Growth Regul; 1993 Mar; 3(1):37-40. PubMed ID: 7683525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
    Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
    Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties.
    Peterkofsky B; Gosiewska A; Wilson S; Kim YR
    Arch Biochem Biophys; 1998 Sep; 357(1):101-10. PubMed ID: 9721188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P; Liu B; Li G; Wu L; Yu M; Ou Y; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the amniotic fluid insulin-like growth factor binding protein-1 phosphorylation sites and propensity to proteolysis of the isoforms.
    Dolcini L; Sala A; Campagnoli M; Labò S; Valli M; Visai L; Minchiotti L; Monaco HL; Galliano M
    FEBS J; 2009 Oct; 276(20):6033-46. PubMed ID: 19765076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
    Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM
    Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
    Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
    J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.
    Street ME; Seghini P; Fieni S; Ziveri MA; Volta C; Martorana D; Viani I; Gramellini D; Bernasconi S
    Eur J Endocrinol; 2006 Oct; 155(4):567-74. PubMed ID: 16990656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal blood and amniotic fluid insulin-like growth factor detection and amniotic cavity drug delivery for early diagnosis and management of fetal growth restriction].
    Chen HX; Wang XC; Liu HN; Wang TB
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1158-60. PubMed ID: 16174587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic IGF-I supplementation of growth-restricted fetal sheep alters IGF-I and IGF receptor type 1 mRNA and protein levels in placental and fetal tissues.
    Shaikh S; Bloomfield FH; Bauer MK; Phua HH; Gilmour RS; Harding JE
    J Endocrinol; 2005 Jul; 186(1):145-55. PubMed ID: 16002544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
    Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
    Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice.
    Crossey PA; Pillai CC; Miell JP
    J Clin Invest; 2002 Aug; 110(3):411-8. PubMed ID: 12163461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy.
    Davidson S; Hod M; Merlob P; Shtaif B
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):586-92. PubMed ID: 17054458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis.
    Nissum M; Abu Shehab M; Sukop U; Khosravi JM; Wildgruber R; Eckerskorn C; Han VK; Gupta MB
    Mol Cell Proteomics; 2009 Jun; 8(6):1424-35. PubMed ID: 19193607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
    Dubaquié Y; Lowman HB
    Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
    Loukovaara M; Leinonen P; Teramo K; Nurminen E; Andersson S; Rutanen EM
    Diabet Med; 2005 Apr; 22(4):434-9. PubMed ID: 15787669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA; Rosenzweig SA
    Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.